Shareholder Communication March 5, 2020

Dear Redwood Green Corp. Shareholders,

Redwood Green Corp.’s strategy is to run profitable businesses and seek strategic acquisitions and partnerships. Now in my second week as Redwood Green’s CEO, we are quickly working on a refined strategy, and I look forward to providing additional information about that to our shareholders in the near future. Be assured that we will continue to operate our businesses with the highest integrity, respecting business fundamentals and the law. We will consistently remain fully compliant with the laws and regulations governing the cannabis industry.

Over the last two weeks, I have spent considerable time on the ground reviewing operations and facilities at our Denver cultivation and dispensary subsidiary, which has been generating revenue for nearly 10 years.

I want to reassure RDGC shareholders that, while we have and continue to be in discussions with PharmaCielo Ltd. about a business relationship for the importation of CBD isolate, and we value our business relationship, we are in no way reliant upon the company for any aspect of our current operations or anticipated directions of continued growth.

I appreciate everyone’s patience, in light of the circumstances, in allowing me to get settled in my new role. Please reach out with any questions to our Investor Relations Director, Jeremie St-Pierre, at or +1 303 222 8092 or toll free at +1 833 817 7185.


Michael Saxon
Chief Executive Officer and Board Director
Redwood Green Corp.

More information:

Investor inquiries:
Direct: +1 303 222 8092

To have Redwood Green Corp. communications
sent directly to your email, please subscribe here.

This message is for information purposes only. Redwood Green Corp. (“Redwood Green” or the “Company”) makes no representations, warranties or covenants, express or implied, including of correctness, reliability or accuracy, all of which are expressly denied and disclaimed to the maximum extent permitted by law. This message should not be relied upon as a basis for any investment decision, and unless otherwise expressly stated, is neither an offer nor the solicitation of an offer to sell or purchase any investment. You should consult with your own professional advisors to evaluate independently the risks, consequences and suitability of any contemplated investment. Redwood Green can be contacted by email at

This email message may contain forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or “recurring” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as demand for the Company’s products, internal funding and the financial condition of the Company, product roll-out, competition, technological changes, and other commercial matters involving the Company, its products and the markets in which the Company operates, as well as general economic conditions, which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this email message. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Except as required by law, we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. However, any further disclosures made on related subjects in subsequent reports should be consulted.

Caution Regarding Cannabis Operations in the United States

Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve Redwood Green of liability under US federal law, nor will it provide a defense to any federal proceeding which may be brought against Redwood Green. Enforcement of federal laws in the United States remains a significant risk to the business of Redwood Green and any proceedings brought against Redwood Green thereunder may adversely affect the Company’s operations and financial performance.